Article Results (Showing 1 - 6 of 6) RSS Alert
-
TAKING STOCK
BANKING AND FINANCE
Bradford Bingley forecast that the buy-to-let market, in which it specialises, will hold up better than the...
Evening Standard; London (UK), 07/26/07 · More from publication -
Broker Snaps: Shire
Byline: NO BYLINE 1,184p +23p Broker says BUY DRUGS group Shire was up again yesterday thanks to a JP Morgan price target rise, to 1,375p...
Scotsman (Edinburgh, Scotland), The, 04/27/07 · More from publication -
Tonic for Shire as US gives drug green light
DRUGMAKER Shire found cause to celebrate today as the City continued to digest news that US regulators have approved the use of Elaprase, a...
Evening Standard; London (UK), 07/25/06 by MICKEY CLARK · More from publication -
Tonic for Shire as US gives drug green light
DRUGMAKER Shire found cause to celebrate today as the City continued to digest news that US regulators have approved the use of Elaprase, a...
Evening Standard; London (UK), 07/25/06 by MICKEY CLARK · More from publication -
WALL STREET CHOICE: ADHD PATCH APPROVAL MEANS 'FAT' RATING FOR SHIRE
Annie Cheng, J.P. Morgan Stock: Shire Pharmaceuticals Rating: Overweight Price: $49.26 52-week range: $30.28-$50.30 The FDA approved Daytrana...
Medical Marketing and Media, 05/01/06 · More from publication -
LONDON MARKET
THURSDAY ENERGY stocks led the FTSE 100 Index to a sixth consecutive day of losses after the price of oil fell off its record highs.
...
Daily Post; Liverpool (UK), 08/19/05 · More from publication
